0001209191-21-046170.txt : 20210709 0001209191-21-046170.hdr.sgml : 20210709 20210709161909 ACCESSION NUMBER: 0001209191-21-046170 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210708 FILED AS OF DATE: 20210709 DATE AS OF CHANGE: 20210709 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Trainer John CENTRAL INDEX KEY: 0001843820 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40045 FILM NUMBER: 211083024 MAIL ADDRESS: STREET 1: C/O NEXIMMUNE, INC. STREET 2: 9119 GAITHER ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20877 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NexImmune, Inc. CENTRAL INDEX KEY: 0001538210 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9119 GAITHER ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 301-825-9810 MAIL ADDRESS: STREET 1: 9119 GAITHER ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-07-08 0 0001538210 NexImmune, Inc. NEXI 0001843820 Trainer John C/O NEXIMMUNE, INC. 9119 GAITHER ROAD GAITHERSBURG MD 20877 0 1 0 0 Chief Financial Officer Common Stock 2021-07-08 4 M 0 3432 5.17 A 61770 D Stock Option (right to buy) 5.17 2021-07-08 4 M 0 3432 0.00 D 2030-03-04 Common Stock 3432 102949 D This option vests as to 25% of the shares on January 8, 2021 with the remainder vesting in equal installments every month thereafter, beginning on January 8, 2021 and ending on January 8, 2024. /s/ Ilse Johnson, Attorney-in-fact 2021-07-09